National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines in Oncology — Neuroendocrine Tumors

Matthew H. Kulke, MD, Chair, et al

NCCN Clinical Practice Guidelines in Oncology. 2017 February; Version 1.2017: 1-116

“The NCCN Guidelines® are a comprehensive set of guidelines detailing the sequential management decisions and interventions that currently apply to 97 percent of cancers affecting patients in the United States. In addition, separate guidelines provide recommendations for some of the key cancer prevention and screening topics as well as supportive care considerations. The NCCN Guidelines provide recommendations based on the best evidence available at the time they are derived. Because new data are published continuously, it is essential that the NCCN Guidelines also be continuously updated and revised to reflect new data and clinical information that may add to or alter current clinical practice standards. The intent of the NCCN Guidelines is to assist in the decision-making process of individuals involved in cancer care—including physicians, nurses, pharmacists, payers, patients and their families—with the ultimate goal of advancing patient care in the fight against cancer.”

The 2017 guidelines for Neuroendocrine Tumors can be found here:

Print Friendly, PDF & Email